| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |